NEW HOPE, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients through ...

Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, "Orchestra BioMed" or the "Company"), a biomedical innovation company accelerating high-impact technologies ...

Medtronic plc MDT is scheduled to report second-quarter fiscal 2025 results on Nov. 19, before the opening bell. In the last reported quarter, the company’s adjusted earnings of $1.23 exceeded the ...

The "Plaque Modification Devices - Market Insights, Competitive Landscape, Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.The plaque modification devices market was valued ...

The global balloon catheter market is set to experience substantial growth over the next decade, with a projected compound annual growth rate (CAGR) of 4.3% from 2023 to 2033, according to a new ...

The first-ever pacemaker to include Managed Ventricular Pacing (MVP®), the EnRhythm™ Pacing System promotes intrinsic conduction and is clinically proven to significantly reduce unnecessary ...

The results in patients with long, complex lesions are better than or equal to those of surgery, but without the ...

Oct. 30, 2024 — Chronic, low-level lead poisoning is a major risk factor for cardiovascular disease in adults and cognitive deficits in children, even at levels previously thought to be safe ...

All blood vessels are specifically structured to perform their function. For example, a capillary is microscopically thin to allow gases to exchange, the arteries are tough and flexible to cope ...

the diameter of the artery at the site of the filtration element placement should be between 2.5–7 mm Silk Road Medical Enroute Transcarotid Neuroprotection System Robust flow reversal Proximal ...